Provided by Tiger Trade Technology Pte. Ltd.

Urogen Pharma Ltd.

43.09
-0.5300-1.22%
Post-market: 43.090.00000.00%19:49 EDT
Volume:749.05K
Turnover:31.98M
Market Cap:2.10B
PE:-21.87
High:44.86
Open:43.17
Low:42.00
Close:43.62
52wk High:50.81
52wk Low:15.86
Shares:48.68M
Float Shares:43.35M
Volume Ratio:1.18
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9700
EPS(LYR):-3.1901
ROE:-1481.26%
ROA:-18.06%
PB:-15.84
PE(LYR):-13.51

Loading ...

Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 18, 2024

Major Issues Report

Form 8-K - Current report
Jan 02, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 28, 2023

Correspondence

Form CORRESP - Correspondence
Nov 15, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 13, 2023

Correspondence

Form CORRESP - Correspondence
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jul 27, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Major Issues Report

8-K - Current report